132
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mental Disorders, Comorbidity and Suicidal Behavior: Results from the National Comorbidity Survey Replication

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mental disorders are among the strongest predictors of suicide attempts. However, little is known about which disorders are uniquely associated with suicidal behavior due to high levels of psychiatric comorbidity. We examined the unique associations between individual disorders and subsequent suicidal behavior (suicide ideation, plans, and attempts) using data from the National Comorbidity Survey Replication, a nationally representative household survey of 9,282 US adults. Results revealed that approximately 80% of suicide attempters in the US have a temporally prior mental disorder. Anxiety, mood, impulse-control, and substance disorders all significantly predict subsequent suicide attempts in bivariate analyses (odds ratios=2.7-6.7); however, these associations decrease substantially in multivariate analyses controlling for comorbidity (odds ratios=1.5-2.3) but remain statistically significant in most cases. Disaggregation of the observed effects reveals that depression predicts suicide ideation, but not suicide plans or attempts among those with ideation. Instead, disorders characterized by severe anxiety/agitation (e.g., PTSD) and poor impulse-control (e.g., conduct disorder, substance disorders) predict which suicide ideators go on to make a plan or attempt. These results advance understanding of the unique associations between mental disorders and different forms of suicidal behavior. Future research must further delineate the mechanisms through which people come to think about suicide and progress from suicidal thoughts to attempts.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: not found
          • Article: not found

          Diagnostic and statistical manual of mental disorders.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

            Little is known about the general population prevalence or severity of DSM-IV mental disorders. To estimate 12-month prevalence, severity, and comorbidity of DSM-IV anxiety, mood, impulse control, and substance disorders in the recently completed US National Comorbidity Survey Replication. Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using a fully structured diagnostic interview, the World Health Organization World Mental Health Survey Initiative version of the Composite International Diagnostic Interview. Nine thousand two hundred eighty-two English-speaking respondents 18 years and older. Twelve-month DSM-IV disorders. Twelve-month prevalence estimates were anxiety, 18.1%; mood, 9.5%; impulse control, 8.9%; substance, 3.8%; and any disorder, 26.2%. Of 12-month cases, 22.3% were classified as serious; 37.3%, moderate; and 40.4%, mild. Fifty-five percent carried only a single diagnosis; 22%, 2 diagnoses; and 23%, 3 or more diagnoses. Latent class analysis detected 7 multivariate disorder classes, including 3 highly comorbid classes representing 7% of the population. Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)

              This paper presents an overview of the World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) and a discussion of the methodological research on which the development of the instrument was based. The WMH‐CIDI includes a screening module and 40 sections that focus on diagnoses (22 sections), functioning (four sections), treatment (two sections), risk factors (four sections), socio‐demographic correlates (seven sections), and methodological factors (two sections). Innovations compared to earlier versions of the CIDI include expansion of the diagnostic sections, a focus on 12‐month as well as lifetime disorders in the same interview, detailed assessment of clinical severity, and inclusion of information on treatment, risk factors, and consequences. A computer‐assisted version of the interview is available along with a direct data entry software system that can be used to keypunch responses to the paper‐and‐pencil version of the interview. Computer programs that generate diagnoses are also available based on both ICD‐10 and DSM‐IV criteria. Elaborate CD‐ROM‐based training materials are available to teach interviewers how to administer the interview as well as to teach supervisors how to monitor the quality of data collection. Copyright © 2004 Whurr Publishers Ltd.
                Bookmark

                Author and article information

                Journal
                9607835
                20545
                Mol Psychiatry
                Molecular psychiatry
                1359-4184
                1476-5578
                9 April 2009
                31 March 2009
                August 2010
                1 February 2011
                : 15
                : 8
                : 868-876
                Affiliations
                [1 ]Department of Psychology, Harvard University, Cambridge, MA, USA
                [2 ]Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
                Author notes
                Correspondence to: Dr MK Nock, Department of Psychology, Harvard University, 33 Kirkland Street, Cambridge, MA 02138, USA; E-mail: nock@ 123456wjh.harvard.edu ; Telephone: (617) 496-4484, Fax: (617) 496-9462.
                Send correspondence to ncs@ 123456hcp.med.harvard.edu .

                Collaborating NCS-R investigators: Ronald C. Kessler (Principal Investigator, Harvard Medical School), Kathleen Merikangas (Co-Principal Investigator, NIMH), James Anthony (Michigan State University), William Eaton (The Johns Hopkins University), Meyer Glantz (NIDA), Doreen Koretz (Harvard University), Jane McLeod (Indiana University), Mark Olfson (New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University), Harold Pincus (University of Pittsburgh), Greg Simon (Group Health Cooperative), Michael Von Korff (Group Health Cooperative), Philip Wang (Harvard Medical School), Kenneth Wells (UCLA), Elaine Wethington (Cornell University), and Hans-Ulrich Wittchen (Max Planck Institute of Psychiatry; Technical University of Dresden).

                Article
                nihpa101809
                10.1038/mp.2009.29
                2889009
                19337207
                95a0f3f4-c0db-4100-b9e7-3e1a18144446
                History
                Funding
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: U13 MH066849-07 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: U01 MH060220-08 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R03 TW006481-03 ||TW
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH077883-02 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH070884-04 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 MH069864-04 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: Fogarty International Center : FIC
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA016558-06 ||DA
                Categories
                Article

                Molecular medicine
                epidemiology,mental disorders,psychopathology,comorbidity,ncs-r,suicide,suicidal ideation,suicide attempt

                Comments

                Comment on this article